Emmis Acquisition (EMIS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Emmis Acquisition Corp   (NASDAQ: EMIS)


Emmis Acquisition 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Emmis Acquisition 's ROA in the second quarter of 2026?
Emmis Acquisition Corp achieved a return on average assets (ROA) of 2.19 % in its second quarter of 2026, this is above EMIS's average return on assets of -19.31%.
Emmis Acquisition Corp assets over the 12 months ending in its second quarter of 2026 are valued at $118 million

Despite the company's net income deteriorating, Emmis Acquisition was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 188 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from to 1818.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
II. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 193510 % 2183.33 % 1681.91 % 1346.78 % -99.39 %
Y / Y Net Income Change - -83.95 % -79.29 % - -
Net Income (TTM) in million 3 2 7 10 5
Return On Assets (TTM) 2.19 % 2.06 % 11.55 % 32.66 % 107.5 %
EMIS's Total Ranking # 1818 # # 137 # 42 #
Total Assets (TTM) in million 119 118 117 116 0
Seq. Total Assets Change 0.63 % 0.85 % 0.73 % 189274.87 % -98.81 %
Seq. Net Income Change -23.05 % 4.32 % - - -



Return On Assets Company Ranking
Within: No.
Industry # 67
Sector # 189
Overall # 1806

Return On Assets Statistics
High Average Low
1220.25 %
-19.31 %
-1064.51 %
(Jun 30 2014)   (Mar 31 2015)





Financial Statements
Emmis Acquisition 's Assets $ 119 million EMIS's Balance sheet
Emmis Acquisition 's Income $ 1 million Quarterly EMIS's Income Statement
EMIS's Income by Division See EMIS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
(Dec 31 2014)
FY 2014
(Dec 31 2013)
FY 2013
Y / Y Total Assets Change 1681.91 % -58.36 % 164.03 % 20.27 % -96.71 %
Total Assets in million 117 7 16 6 5
Y / Y Net Income Change - - - - -
Net Income in million 1 -10 -40 -25 -21
Annual Return On Assets 0.72 % -152.51 % -255.41 % -423.85 % -420.55 %




Comment on EMIS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 0.72 % compared to prior year, due to annual net income growth of % to $0.84 million, while value of Emmis Acquisition 's overall assets grew just by 1681.91 % to $117.32 million, compared to $117.32 a year before.


More Return On Assets Ratios
EMIS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EMIS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EMIS's Competitors
Subscribers only: Roa for Emmis Acquisition 's Suppliers
Subscribers only: Return On Assets for EMIS's Customers

You may also want to know
EMIS's Roi EMIS's Inventory Turnover Ratio EMIS's Growth Rates EMIS's Dividend Comparisons
EMIS's Profitability Ratios EMIS's Asset Turnover Ratio EMIS's Dividend Growth
EMIS's Roe EMIS's Valuation Ratios EMIS's Financial Strength Ratios EMIS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Brightspring Health Services Inc   5.93 %
Amneal Pharmaceuticals Inc   5.90 %
Siga Technologies Inc  5.73 %
Medtronic Plc  5.71 %
Labcorp Holdings Inc   5.40 %
Merit Medical Systems Inc  5.34 %
Sotera Health Company  5.03 %
Vericel Corporation  5.02 %
Kewaunee Scientific Corporation  4.96 %
Pacs Group Inc   4.78 %
Amphastar Pharmaceuticals Inc   4.70 %
Abbvie Inc   4.68 %
The Cooper Companies Inc   4.57 %
IMPACT BIOMEDICAL INC.  4.47 %
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %


Date modified: 2026-09-26T07:43:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.